Study Stopped
Terminated: Study halted prematurely and will not resume; participants are no longer being examined or receiving intervention. Lack of data to demonstrate sufficient power.
LACE+ and MRS Score Readmission Rate Assessment
Comparing the Predictive Strength of the LACE+ Index With the MedWise Rise Score on Hospital Readmission Rates: a Non-inferiority Observational Study
1 other identifier
observational
100
1 country
1
Brief Summary
A study to demonstrate that the LACE+ score in non-inferior to the medication risk score when predicting 30-day readmission post hospital discharge.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 24, 2020
CompletedFirst Posted
Study publicly available on registry
April 28, 2020
CompletedStudy Start
First participant enrolled
July 7, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2021
CompletedMarch 17, 2022
March 1, 2022
8 months
April 24, 2020
March 2, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Readmission
Readmission within 30-days post hospital discharge
2018 - 2019
Study Arms (2)
Readmitted
Patients that were readmitted within 30 days post hospital discharge
Not readmitted
Patients that were not readmitted within 30 days post hospital discharge
Interventions
Pharmacist-delivered comprehensive medication review
Eligibility Criteria
Information will be collected from an internal data collection excel used to provide monthly outcome intervention reports to the local Tucson hospital.
You may qualify if:
- Those referred to receive transition of care services between January 2018 to December 2019 and were discharged on 10 or more medications.
You may not qualify if:
- years or older
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tabula Rasa HealthCare
Tucson, Arizona, 85701, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Jennifer Bingham, PharmD
Tabula Rasa HealthCare
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 24, 2020
First Posted
April 28, 2020
Study Start
July 7, 2020
Primary Completion
March 1, 2021
Study Completion
March 1, 2021
Last Updated
March 17, 2022
Record last verified: 2022-03